Atherosclerosis is a multifactorial disease influenced by genetics, lifestyle and
environmental factors. Despite therapeutic advances that reduce the risk of cardiovascular …

Low high-density lipoprotein cholesterol (HDL-C) characterizes an atherogenic dyslipidemia
that reflects adverse lifestyle choices, impaired metabolism, and increased cardiovascular …

Since the seminal breakthrough of treating diabetic patients with insulin in the 1920s, there
has been great interest in developing other proteins and their peptide mimetics as therapies …

Atherosclerosis as the leading cause of the cardiovascular disease is closely related to
cholesterol deposition within subendothelial areas of the arteries. Significantly, early …

Abstract Introduction Atherosclerotic Coronary Artery Disease (ASCAD) is the leading cause
of mortality worldwide. Novel therapeutic approaches aiming to improve the atheroprotective …

Apolipoprotein (Apo)-based mimetic peptides have been shown to reduce atherosclerosis.
Most of the ApoC-II and ApoE mimetics exert anti-atherosclerotic effects by improving lipid …

Background: High-density lipoprotein (HDL) plays an antiatherogenic role by mediating
reverse cholesterol transport (RCT), antioxidation, anti-inflammation, and endothelial cell …

It is crucial to understand the glucose control within our bodies. Bariatric/metabolic
surgeries, including laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass …

Apolipoproteins (Apos) play an important role in regulating plasma lipid concentration.
Complex disorders of Apos are highly related with diabetes mellitus, cardiovascular and …

Abstract Apolipoprotein E (apoE, protein; APOE, gene) involves in cholesterol recycling and
redistribution by mediating lipoprotein pathways unique to central nervous system (CNS) …